Venus Concept to Release First Quarter of Fiscal Year 2022 Financial Results on May 12, 2022

Rhea-AI Summary

Venus Concept (NASDAQ: VERO) has announced that it will release its first quarter fiscal year 2022 financial results on May 12, 2022, after market close. A conference call to discuss these results will take place at 5:00 p.m. Eastern Time, including a question and answer session for participants. Interested parties can join the call via phone or through a live webcast on the company's investor relations website.

This release marks an important date for investors looking to understand the company's performance in the competitive medical aesthetic technology market.

Positive

• Upcoming release of first quarter fiscal year 2022 financial results, indicating timely financial reporting.
• Company operates a subscription-based sales strategy in North America, providing potential for recurring revenue.

Negative

• None.

TORONTO, April 04, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that first quarter of fiscal year 2022 financial results will be released after the market closes on Thursday, May 12, 2022.

Management will host a conference call at 5:00 p.m. Eastern Time on May 12, 2022 to discuss the results of the quarter with a question and answer session. Those who would like to participate may dial 877-407-2991 (201-389-0925 for international callers) and provide access code 13728704. A live webcast of the call will also be provided on the investor relations section of the Company's website at ir.venusconcept.com.

For those unable to participate, a replay of the call will be available for two weeks at 877-660-6853 (201-612-7415 for international callers); access code 13728704. The webcast will be archived at ir.venusconcept.com.

About Venus Concept

Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reach in over 60 countries and 18 direct markets. Venus Concept focuses its product sales strategy on a subscription-based business model in North America and in its well-established direct global markets. Venus Concept’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Glow, Venus Bliss, Venus BlissMAX, Venus Epileve and Venus Viva MD. Venus Concept’s hair restoration systems include NeoGraft®, an automated hair restoration system that facilitates the harvesting of follicles during a FUE process and the ARTAS® and ARTAS iX® Robotic Hair Restoration systems, which harvest follicular units directly from the scalp and create recipient implant sites using proprietary algorithms. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, Aperture Venture Partners, and Masters Special Situations.

FAQ

When will Venus Concept release its first quarter fiscal year 2022 financial results?

Venus Concept will release its financial results on May 12, 2022, after the market closes.

What time is the conference call for Venus Concept's first quarter results?

The conference call will be held at 5:00 p.m. Eastern Time on May 12, 2022.

How can I access the webcast of Venus Concept's conference call?

The webcast can be accessed on the investor relations section of Venus Concept's website.

Will there be a replay available for the conference call?

Yes, a replay of the call will be available for two weeks following the event.

What is Venus Concept's business model?

Venus Concept utilizes a subscription-based business model for its product sales in North America and other direct markets.